Breaking

Jayapal floats reparations for illegal immigrants impacted by Trump crackdown, demands prosecutions
Swalwell threatens FBI with legal action as Patel reportedly weighs ‘Fang Fang’ files release
Democrats pounce on $4 a gallon gas, blame Trump’s Iran war for ‘broken promise’
Supreme Court blocks Colorado’s so-called ‘conversion therapy’ ban on First Amendment grounds
DHS rips Jimmy Kimmel for mocking Secretary Markwayne Mullin’s plumbing background
SEE IT: Lawmakers caught on vacation amid record-breaking shutdown while DHS workers go unpaid
Profanity-fueled social media posts heat up Arkansas Republican runoff for secretary of state
More key US allies block military flights as Iran war rift widens with Trump

Investing
Business
Politics
World
Search for:

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Lahontan Announces Private Placement

Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit

CHARBONE presentera a la conference Hydrogen East et annonce le developpement d’un hub d’approvisionnement dans le marche de l’Atlantique via sa filiale

Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (212)
- Investing (1,934)
- Politics (2,386)
- World (226)

Disclaimer: SecureStockStrategies.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2026 securestockstrategies.com | All Rights Reserved

Top

Investing
Business
Politics
World

Type above and press Enter to search. Press Esc to cancel.